sphingosylphosphorylcholine

sphingosylphosphorylcholine is a lipid of Sphingolipids (SP) class. Sphingosylphosphorylcholine is associated with abnormalities such as Cerebral Vasospasm, Subarachnoid Hemorrhage, Atherosclerosis, Hypertensive disease and Niemann-Pick Diseases. The involved functions are known as MAP kinase kinase activity, JUN kinase activity, Phosphorylation, biphenyl synthase activity and Cell Death. Sphingosylphosphorylcholine often locates in Adipose tissue, Protoplasm, Body tissue, Membrane and Extracellular. The associated genes with sphingosylphosphorylcholine are UCN3 gene, MAPK9 gene, JUN gene, NAA50 gene and P4HTM gene. The related lipids are Lysophospholipids, lysophosphatidic acid, Lysophosphatidylcholines, Sphingolipids and Saponin. The related experimental models are Mouse Model.

Cross Reference

Introduction

To understand associated biological information of sphingosylphosphorylcholine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with sphingosylphosphorylcholine?

sphingosylphosphorylcholine is suspected in Atherosclerosis, Niemann-Pick Diseases, Hypercholesterolemia, Dermatitis, Atopic, Chronic eczema, Cerebral Vasospasm and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with sphingosylphosphorylcholine

MeSH term MeSH ID Detail
Lupus Erythematosus, Systemic D008180 43 associated lipids
Insulinoma D007340 28 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Seizures D012640 87 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Endotoxemia D019446 27 associated lipids
Niemann-Pick Disease, Type A D052536 1 associated lipids
Niemann-Pick Disease, Type B D052537 1 associated lipids
Total 8

PubChem Associated disorders and diseases

What pathways are associated with sphingosylphosphorylcholine

Lipid pathways are not clear in current pathway databases. We organized associated pathways with sphingosylphosphorylcholine through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with sphingosylphosphorylcholine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with sphingosylphosphorylcholine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with sphingosylphosphorylcholine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with sphingosylphosphorylcholine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with sphingosylphosphorylcholine?

Mouse Model

Mouse Model are used in the study 'Sphingosylphosphorylcholine induces a hypertrophic growth response through the mitogen-activated protein kinase signaling cascade in rat neonatal cardiac myocytes.' (Sekiguchi K et al., 1999).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with sphingosylphosphorylcholine

Download all related citations
Per page 10 20 50 100 | Total 248
Authors Title Published Journal PubMed Link
Afrasiabi E et al. Sphingosylphosphorylcholine enhances calcium entry in thyroid FRO cells by a mechanism dependent on protein kinase C. 2006 Cell. Signal. pmid:16490345
Czyborra C et al. Indomethacin differentiates the renal effects of sphingosine-1-phosphate and sphingosylphosphorylcholine. 2006 Naunyn Schmiedebergs Arch. Pharmacol. pmid:16521006
Katayama T et al. Blebbistatin inhibits sphingosylphosphorylcholine-induced contraction of collagen-gel fiber populated by vascular smooth-muscle cells. 2006 J. Pharmacol. Sci. pmid:17072099
Li S et al. Intracellular signal transduction for migration and actin remodeling in vascular smooth muscle cells after sphingosylphosphorylcholine stimulation. 2006 Am. J. Physiol. Heart Circ. Physiol. pmid:16899767
Jeon ES et al. Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-beta-dependent mechanism. 2006 J. Cell. Sci. pmid:17105765
Ryu SK et al. Augmented sphingosylphosphorylcholine-induced Ca2+-sensitization of mesenteric artery contraction in spontaneously hypertensive rat. 2006 Naunyn Schmiedebergs Arch. Pharmacol. pmid:16521007
Kim DS et al. Sphingosylphosphorylcholine-induced ERK activation inhibits melanin synthesis in human melanocytes. 2006 Pigment Cell Res. pmid:16524430
Morikage N et al. Cholesterol primes vascular smooth muscle to induce Ca2 sensitization mediated by a sphingosylphosphorylcholine-Rho-kinase pathway: possible role for membrane raft. 2006 Circ. Res. pmid:16825579
Lee HY et al. Sphingosylphosphorylcholine stimulates human monocyte-derived dendritic cell chemotaxis. 2006 Acta Pharmacol. Sin. pmid:17007744
Hemmings DG Signal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine. 2006 Naunyn Schmiedebergs Arch. Pharmacol. pmid:16570136
Jin Y et al. Human resting CD16-, CD16+ and IL-2-, IL-12-, IL-15- or IFN-alpha-activated natural killer cells differentially respond to sphingosylphosphorylcholine, lysophosphatidylcholine and platelet-activating factor. 2005 Eur. J. Immunol. pmid:16078278
Suresh S et al. Connections between single-cell biomechanics and human disease states: gastrointestinal cancer and malaria. 2005 Acta Biomater pmid:16701777
Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. 2005 J. Biol. Chem. pmid:16498716
Kamanna VS et al. Bioactive lysophospholipids and mesangial cell intracellular signaling pathways: role in the pathobiology of kidney disease. 2005 Histol. Histopathol. pmid:15736064
Sakagami H et al. Biochemical and molecular characterization of a novel choline-specific glycerophosphodiester phosphodiesterase belonging to the nucleotide pyrophosphatase/phosphodiesterase family. 2005 J. Biol. Chem. pmid:15788404
Mogi C et al. Sphingosylphosphorylcholine antagonizes proton-sensing ovarian cancer G-protein-coupled receptor 1 (OGR1)-mediated inositol phosphate production and cAMP accumulation. 2005 J. Pharmacol. Sci. pmid:16210776
Im DS Two ligands for a GPCR, proton vs lysolipid. 2005 Acta Pharmacol. Sin. pmid:16297340
Jeon ES et al. Sphingosylphosphorylcholine generates reactive oxygen species through calcium-, protein kinase Cdelta- and phospholipase D-dependent pathways. 2005 Cell. Signal. pmid:15722202
Jeon ES et al. Role of MEK-ERK pathway in sphingosylphosphorylcholine-induced cell death in human adipose tissue-derived mesenchymal stem cells. 2005 Biochim. Biophys. Acta pmid:15866480
Piao YJ et al. Involvement of urokinase-type plasminogen activator in sphingosylphosphorylcholine-induced angiogenesis. 2005 Exp. Dermatol. pmid:15854129
Lu X and Bittman R Synthesis of a photoactivatable (2S,3R)-sphingosylphosphorylcholine analogue. 2005 J. Org. Chem. pmid:15932314
Zhu MJ et al. Induction of connective tissue growth factor expression by sphingosylphosphorylcholine in cultured human skin fibroblasts. 2005 Exp. Dermatol. pmid:15946238
van Diggelen OP et al. A new fluorimetric enzyme assay for the diagnosis of Niemann-Pick A/B, with specificity of natural sphingomyelinase substrate. 2005 J. Inherit. Metab. Dis. pmid:16151905
Schubert R Non-capacitative calcium entry--extension of the possibilities for calcium entry in vascular tissue. 2005 Cardiovasc. Res. pmid:16111665
Kim KS et al. GPR4 plays a critical role in endothelial cell function and mediates the effects of sphingosylphosphorylcholine. 2005 FASEB J. pmid:15857892
Thomas GD et al. Sphingosylphosphorylcholine-induced vasoconstriction of pulmonary artery: activation of non-store-operated Ca2+ entry. 2005 Cardiovasc. Res. pmid:15950201
Yagmurlu A et al. A novel approach for preventing esophageal stricture formation: sphingosylphosphorylcholine-enhanced tissue remodeling. 2004 Pediatr. Surg. Int. pmid:15185106
Murakami N et al. G2A is a proton-sensing G-protein-coupled receptor antagonized by lysophosphatidylcholine. 2004 J. Biol. Chem. pmid:15280385
Kostenis E Novel clusters of receptors for sphingosine-1-phosphate, sphingosylphosphorylcholine, and (lyso)-phosphatidic acid: new receptors for "old" ligands. 2004 J. Cell. Biochem. pmid:15258916
Kye KC et al. Signaling events during induction of plasminogen activator inhibitor-1 expression by sphingosylphosphorylcholine in cultured human dermal fibroblasts. 2004 J. Invest. Dermatol. pmid:15175025
Miura Y et al. Hydrolysis of sphingosylphosphocholine by neutral sphingomyelinases. 2004 FEBS Lett. pmid:14741383
Li Z et al. The critical micelle concentrations of lysophosphatidic acid and sphingosylphosphorylcholine. 2004 Chem. Phys. Lipids pmid:15172836
Deguchi H et al. Sphingolipids as bioactive regulators of thrombin generation. 2004 J. Biol. Chem. pmid:14722105
Teisseyre A and Michalak K The influence of zinc on the modulatory effect of sphingosylphosphorylcholine on Kv1.3 channels in human T lymphocytes. 2004 Eur. Biophys. J. pmid:15014908
Hedemann J et al. Comparison of noradrenaline and lysosphingolipid-induced vasoconstriction in mouse and rat small mesenteric arteries. 2004 Auton Autacoid Pharmacol pmid:15541015
Ignatov A et al. Role of the G-protein-coupled receptor GPR12 as high-affinity receptor for sphingosylphosphorylcholine and its expression and function in brain development. 2003 J. Neurosci. pmid:12574419
Yasukochi M et al. Ca2+ and voltage dependence of cardiac ryanodine receptor channel block by sphingosylphosphorylcholine. 2003 Pflugers Arch. pmid:12632186
Beil M et al. Sphingosylphosphorylcholine regulates keratin network architecture and visco-elastic properties of human cancer cells. 2003 Nat. Cell Biol. pmid:12942086
Suhr KB et al. Sphingosylphosphorylcholine stimulates cellular fibronectin expression through upregulation of IL-6 in cultured human dermal fibroblasts. 2003 Arch. Dermatol. Res. pmid:12563540
Altmann C et al. Sphingosylphosphorylcholine, a naturally occurring lipid mediator, inhibits human platelet function. 2003 Br. J. Pharmacol. pmid:12569068
Okamoto R et al. Sphingosylphosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis. 2003 J. Lipid Res. pmid:12518027
Altmann C et al. Comparison of signalling mechanisms involved in rat mesenteric microvessel contraction by noradrenaline and sphingosylphosphorylcholine. 2003 Br. J. Pharmacol. pmid:12522098
Higuchi K et al. Sphingosylphosphorylcholine is a Melanogenic Stimulator for Human Melanocytes. 2003 Pigment Cell Res. pmid:14629725
Brailoiu E et al. Modulation of spontaneous transmitter release from the frog neuromuscular junction by interacting intracellular Ca(2+) stores: critical role for nicotinic acid-adenine dinucleotide phosphate (NAADP). 2003 Biochem. J. pmid:12749764
Clair T et al. Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. 2003 Cancer Res. pmid:14500380
Brailoiu E and Dun NJ Extra- and intracellular sphingosylphosphorylcholine promote spontaneous transmitter release from frog motor nerve endings. 2003 Mol. Pharmacol. pmid:12761354
Arikawa K et al. Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity. 2003 J. Biol. Chem. pmid:12810709
Schnurbus R et al. Re-evaluation of primary structure, topology, and localization of Scamper, a putative intracellular Ca2+ channel activated by sphingosylphosphocholine. 2002 Biochem. J. pmid:11829755
Neri LM et al. Proliferating or differentiating stimuli act on different lipid-dependent signaling pathways in nuclei of human leukemia cells. 2002 Mol. Biol. Cell pmid:11907274
Somlyo AV New roads leading to Ca2+ sensitization. 2002 Circ. Res. pmid:12142337
Shirao S et al. Sphingosylphosphorylcholine is a novel messenger for Rho-kinase-mediated Ca2+ sensitization in the bovine cerebral artery: unimportant role for protein kinase C. 2002 Circ. Res. pmid:12142343
Xu Y Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction. 2002 Biochim. Biophys. Acta pmid:12069813
Lee T et al. Sphingosylphosphorylcholine-induced contraction of feline ileal smooth muscle cells is mediated by Galphai3 protein and MAPK. 2002 Cell. Signal. pmid:12359304
Nakao F et al. Involvement of Src family protein tyrosine kinases in Ca(2+) sensitization of coronary artery contraction mediated by a sphingosylphosphorylcholine-Rho-kinase pathway. 2002 Circ. Res. pmid:12433841
Meyer zu Heringdorf D et al. Sphingosylphosphorylcholine-biological functions and mechanisms of action. 2002 Biochim. Biophys. Acta pmid:12069827
Liliom K et al. Sphingosylphosphocholine is a naturally occurring lipid mediator in blood plasma: a possible role in regulating cardiac function via sphingolipid receptors. 2001 Biochem. J. pmid:11256963
Higuchi K et al. Sphingosylphosphorylcholine is an activator of transglutaminase activity in human keratinocytes. 2001 J. Lipid Res. pmid:11590211
Miguel BG et al. Sphingolipid derivatives modulate intracellular Ca2+ in rat synaptosomes. 2001 Acta Neurobiol Exp (Wars) pmid:11512408
Carson MJ and Lo D Immunology. The push-me pull-you of T cell activation. 2001 Science pmid:11474091
Lai TS et al. Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase. 2001 Biochemistry pmid:11305905
Nofer JR et al. Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids. 2001 J. Biol. Chem. pmid:11432865
Zhu K et al. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. 2001 J. Biol. Chem. pmid:11535583
Kabarowski JH et al. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. 2001 Science pmid:11474113
Meyer zu Heringdorf D et al. Stimulation of intracellular sphingosine-1-phosphate production by G-protein-coupled sphingosine-1-phosphate receptors. 2001 Eur. J. Pharmacol. pmid:11239914
Lyons JM and Karin NJ A role for G protein-coupled lysophospholipid receptors in sphingolipid-induced Ca2+ signaling in MC3T3-E1 osteoblastic cells. 2001 J. Bone Miner. Res. pmid:11697799
Lynch KR and Macdonald TL Structure activity relationships of lysophospholipid mediators. 2001 Prostaglandins Other Lipid Mediat. pmid:11324706
Schwartz BM et al. Lysophospholipids increase interleukin-8 expression in ovarian cancer cells. 2001 Gynecol. Oncol. pmid:11330965
Hitomi K et al. Characterization of human recombinant transglutaminase 1 purified from baculovirus-infected insect cells. 2000 Biosci. Biotechnol. Biochem. pmid:11129585
Liliom K et al. Sphingosylphosphorylcholine is a bona fide mediator regulating heart rate. 2000 Ann. N. Y. Acad. Sci. pmid:10818471
Xu Y et al. Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1. 2000 Nat. Cell Biol. pmid:10806476
Kanazawa T et al. Inhibition of cytokinesis by a lipid metabolite, psychosine. 2000 J. Cell Biol. pmid:10811833
Nofer JR et al. Activation of phosphatidylinositol-specific phospholipase C by HDL-associated lysosphingolipid. Involvement in mitogenesis but not in cholesterol efflux. 2000 Biochemistry pmid:11106499
Todoroki-Ikeda N et al. Sphingosylphosphorylcholine induces Ca(2+)-sensitization of vascular smooth muscle contraction: possible involvement of rho-kinase. 2000 FEBS Lett. pmid:11018528
Brandts B et al. Inhibition of muscarinic potassium current by the class III antiarrhythmic drug RP58866 in guinea-pig atrial myocytes. 2000 Pacing Clin Electrophysiol pmid:11139931
Im DS et al. Characterization of a novel sphingosine 1-phosphate receptor, Edg-8. 2000 J. Biol. Chem. pmid:10799507
Bittman R and Verbicky CA Methanolysis of sphingomyelin. Toward an epimerization-free methodology for the preparation of D-erythro-sphingosylphosphocholine. 2000 J. Lipid Res. pmid:11108743
Boguslawski G et al. Sphingosylphosphorylcholine induces endothelial cell migration and morphogenesis. 2000 Biochem. Biophys. Res. Commun. pmid:10833459
Van Brocklyn JR et al. Sphingosine-1-phosphate is a ligand for the G protein-coupled receptor EDG-6. 2000 Blood pmid:10753843
Bischoff A et al. Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro. 2000 Br. J. Pharmacol. pmid:10952677
Bischoff A et al. Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner. 2000 Br. J. Pharmacol. pmid:10952678
Murata N et al. Quantitative measurement of sphingosine 1-phosphate by radioreceptor-binding assay. 2000 Anal. Biochem. pmid:10860507
Chin TY and Chueh SH Distinct Ca(2+) signalling mechanisms induced by ATP and sphingosylphosphorylcholine in porcine aortic smooth muscle cells. 2000 Br. J. Pharmacol. pmid:10742292
Tokura Y et al. Modulation of T-lymphocyte proliferation by exogenous natural ceramides and sphingosylphosphorylcholine. 1999 J. Investig. Dermatol. Symp. Proc. pmid:10536997
Mogami K et al. Sphingosylphosphorylcholine induces cytosolic Ca(2+) elevation in endothelial cells in situ and causes endothelium-dependent relaxation through nitric oxide production in bovine coronary artery. 1999 FEBS Lett. pmid:10471811
Hodgson DM et al. Lysosphingomyelin prevents behavioral aberrations and hippocampal neuron loss induced by the metabotropic glutamate receptor agonist quisqualate. 1999 Prog. Neuropsychopharmacol. Biol. Psychiatry pmid:10509381
Imokawa G et al. Sphingosylphosphorylcholine is a potent inducer of intercellular adhesion molecule-1 expression in human keratinocytes. 1999 J. Invest. Dermatol. pmid:9886270
Rodriguez-Lafrasse C and Vanier MT Sphingosylphosphorylcholine in Niemann-Pick disease brain: accumulation in type A but not in type B. 1999 Neurochem. Res. pmid:9972865
Okamoto H et al. EDG3 is a functional receptor specific for sphingosine 1-phosphate and sphingosylphosphorylcholine with signaling characteristics distinct from EDG1 and AGR16. 1999 Biochem. Biophys. Res. Commun. pmid:10381367
Uehara A et al. Effect of sphingosylphosphorylcholine on the single channel gating properties of the cardiac ryanodine receptor. 1999 FEBS Lett. pmid:10556518
Sekiguchi K et al. Sphingosylphosphorylcholine induces a hypertrophic growth response through the mitogen-activated protein kinase signaling cascade in rat neonatal cardiac myocytes. 1999 Circ. Res. pmid:10571530
Dygas A et al. Exogenous sphingosine 1-phosphate and sphingosylphosphorylcholine do not stimulate phospholipase D in C6 glioma cells. 1999 Acta Biochim. Pol. pmid:10453985
Wójcik M and Barańska J Sphingosine, sphingosylphosphorylcholine and sphingosine 1-phosphate modulate phosphatidylserine homeostasis in glioma C6 cells. 1999 Acta Biochim. Pol. pmid:10453988
Nikmo A et al. Sphingosylphosphorylcholine activates Gq, Gi-2, and Gi-3 in thyroid FRTL-5 cells: implications for the activation of calcium fluxes and Na+-H+ exchange. 1999 Biochem. Biophys. Res. Commun. pmid:10329469
Ancellin N and Hla T Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5. 1999 J. Biol. Chem. pmid:10383399
Calcerrada MC et al. Sphingosylphosphorylcholine increases calcium concentration in isolated brain nuclei. 1999 Neurosci. Res. pmid:10211767
Orlati S et al. Sphingosylphosphorylcholine and sphingosine-1-phosphate mobilize cytosolic calcium through different mechanisms in human airway epithelial cells. 1998 Cell Calcium pmid:9924630
Okamoto H et al. EDG1 is a functional sphingosine-1-phosphate receptor that is linked via a Gi/o to multiple signaling pathways, including phospholipase C activation, Ca2+ mobilization, Ras-mitogen-activated protein kinase activation, and adenylate cyclase inhibition. 1998 J. Biol. Chem. pmid:9765227
Wakita H et al. Sphingosylphosphorylcholine stimulates proliferation and upregulates cell surface-associated plasminogen activator activity in cultured human keratinocytes. 1998 J. Invest. Dermatol. pmid:9506444
Berger A et al. The potent lipid mitogen sphingosylphosphocholine activates the DNA binding activity of upstream stimulating factor (USF), a basic helix-loop-helix-zipper protein. 1998 Biochim. Biophys. Acta pmid:9507145
Meyer zu Heringdorf D et al. Discrimination between plasma membrane and intracellular target sites of sphingosylphosphorylcholine. 1998 Eur. J. Pharmacol. pmid:9726638